Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Refractory Nephrotic Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating mizoribine for efficacy and safety in refractory nephrotic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome

Drugs mentioned

• Mizoribine (mizoribine)

Snippet

Sponsor: Asahi Kasei Therapeutics Corporation | Conditions: Nephrotic Syndrome | Phase 3 | Status: COMPLETED